Ann Neurol

1. MANOUCHEHRINIA A, Fitzgerald KC, Salter A, Marrie RA, et al
   Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis.
   Ann Neurol. 2025 Aug 7. doi: 10.1002/ana.70020.
   

   >> Share

   
   

   
   BMC Neurol

2. AL SHAAIBI K, Phoophiboon V, Burns KEA
   Rhombencephalitis associated with varicella-zoster virus masquerading as Guillain-Barre syndrome.
   BMC Neurol. 2025;25:324.
   

   >> Share

   
   

   
   Brain

3. KALINCIK T, Sharmin S, Roos I, Freedman MS, et al
   Haematopoietic stem cell transplant versus immune-reconstitution therapy in relapsing multiple sclerosis.
   Brain. 2025 Aug 4:awaf286. doi: 10.1093.
   

   >> Share

   
   

   
   Curr Opin Immunol

4. DRAGON DUREY MA, Hamidi H, Darnige L
   Complement in antiphospholipid syndrome, time to target?
   Curr Opin Immunol. 2025;96:102628.
   

   >> Share

   
   
5. MERONI PL, Capobianco E, Tedesco F
   Can we cure antiphospholipid syndrome?
   Curr Opin Immunol. 2025;96:102610.
   

   >> Share

   
   

   
   Diabetes Res Clin Pract

6. BLANCO-CARRASCO AJ, Merino-Torres JF, Rubio Almanza M, Canovas Molina G, et al
   Characterizing the clinical profile and prevalence of people with diabetes attended in the hospital setting by using unstructured healthcare data and natural language processing: the Diabetic@ study.
   Diabetes Res Clin Pract. 2025;226:112214.
   

   >> Share

   
   
7. TALL S, Sylgren I, Virtanen SM, Knip M, et al
   Higher population density protects from type 1 diabetes? Dissecting the literature through meta-analysis.
   Diabetes Res Clin Pract. 2025;226:112272.
   

   >> Share

   
   
8. NGAN J, O'Neal DN, Lee MH, Kong YW, et al
   Revisiting the benefits vs risk profile of sodium-glucose co-transporter inhibitor use in type 1 diabetes. Part B: Risks of sodium-glucose co-transporter inhibitor use in type 1 diabetes and ketoacidosis risk mitigation strategies.
   Diabetes Res Clin Pract. 2025;226:112284.
   

   >> Share

   
   
9. BENSAID S, Allix I, Dubois S, Schaepelynck P, et al
   Optimization of insulin management during postprandial and post-absorptive exercise in adults with type 1 diabetes: DiabraAlgo effectiveness in real life ?
   Diabetes Res Clin Pract. 2025;226:112302.
   

   >> Share

   
   
10. ZHU Q, Wang H, Qu Y, Jiang Y, et al
    Association between long-term serum uric acid variability and diabetic retinopathy: A prospective study in patients with Type 1 and Type 2 diabetes.
    Diabetes Res Clin Pract. 2025;226:112306.
    

    >> Share

    
    
11. YEN IW, Chien JC, Yang YH, Tan EC, et al
    Association between daily insulin Dose, cancer Incidence, and mortality in type 1 diabetes patients.
    Diabetes Res Clin Pract. 2025;226:112290.
    

    >> Share

    
    
12. SARTEAU AC, Couch S, Kosorok MR, Gordon-Larsen P, et al
    Evaluating behavioral goals for eating timing, frequency, and distribution of daily carbohydrate consumption among youth with type 1 diabetes (MyPlan): A single arm pilot and feasibility study.
    Diabetes Res Clin Pract. 2025;226:112321.
    

    >> Share

    
    
13. KIM JY, Kim S, Park SH, Lee JA, et al
    Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: A cross-sectional study.
    Diabetes Res Clin Pract. 2025;226:112325.
    

    >> Share

    
    
14. CHONG KS, Lee YH, Chang YH, Du YF, et al
    Economic burdens of type 1 diabetes and its complications: A nationwide, longitudinal analysis.
    Diabetes Res Clin Pract. 2025;226:112329.
    

    >> Share

    
    
15. CLARO M, Vinals C, Gimenez M, Perea V, et al
    Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes.
    Diabetes Res Clin Pract. 2025;226:112334.
    

    >> Share

    
    
16. JIANG J, Wang P, Jiang J, Zhang T, et al
    Association between metabolic phenotype and diabetic kidney disease in adult-onset type 1 diabetes patients from China: A multi-center cross-sectional study.
    Diabetes Res Clin Pract. 2025;226:112347.
    

    >> Share

    
    
17. HUANG J, Zheng J, Pan X, Qiao J, et al
    Global burden of diabetes in reproductive-age women (1990-2021), with projections to 2045: Systematic analysis of the global burden of disease study 2021.
    Diabetes Res Clin Pract. 2025;226:112349.
    

    >> Share

    
    
18. SANDIN S, Jarnbert-Pettersson H, Simmons D, Backman H, et al
    National trends in offspring birth size in pregnancies with maternal type 1 diabetes in Sweden.
    Diabetes Res Clin Pract. 2025;226:112350.
    

    >> Share

    
    
19. BAAGAR K, Ali H, Ata F, Mohamud K, et al
    Automated insulin delivery for safe fasting and exercise during Ramadan in patients with type 1 diabetes: The active fast study.
    Diabetes Res Clin Pract. 2025;226:112353.
    

    >> Share

    
    
20. IBEAS C, Alarcon K, Herrera I, Sanchez J, et al
    Perception of health system response and lifestyle changes in people with type 1 diabetes during the COVID-19 pandemic in Chile.
    Diabetes Res Clin Pract. 2025;226:112355.
    

    >> Share

    
    
21. MONNIER L, Colette C, Renard E, Benhamou PY, et al
    Glycemic variability and iatrogenic hypoglycemia: how to resolve.
    Diabetes Res Clin Pract. 2025;226:112360.
    

    >> Share

    
    
22. MOOSAVI A, Tabrizi ZA, Eghbali Z, Barzegari A, et al
    Shed light on molecular immunogenetic pathophysiology of type 1 diabetes to improve advanced treatment strategies.
    Diabetes Res Clin Pract. 2025;226:112359.
    

    >> Share

    
    
23. ARDIC M, Erisen MA
    Examining out-of-pocket health expenditures of individuals with Type 1 diabetes: The case of Turkiye.
    Diabetes Res Clin Pract. 2025;226:112362.
    

    >> Share

    
    
24. RODRIGUEZ DE VERA GOMEZ P, Rodriguez Jimenez B, Mayoral Sanchez E, Jodar Sanchez F, et al
    Intermittently scanned continuous glucose monitoring adoption decreases diabetic ketoacidosis hospitalizations and healthcare costs in adults with type 1 diabetes.
    Diabetes Res Clin Pract. 2025;226:112372.
    

    >> Share

    
    
25. CHICO A, Pazos-Couselo M, Nattero-Chavez L, Simo-Servat O, et al
    Beyond glycemic metrics: Real-world benefits of connected insulin pens in type 1 diabetes.
    Diabetes Res Clin Pract. 2025;226:112377.
    

    >> Share

    
    

    
    Intern Med

26. KAWANO H, Otsuka M, Umeda M, Uchida T, et al
    Loeffler Endocarditis with Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination.
    Intern Med. 2025;64:2332-2337.
    

    >> Share

    
    
27. KOTERA T, Kushima R, Haruma K
    Helicobacter pylori Gastritis as an Initial Presentation of Evolving Autoimmune Gastritis: A Report of Two Cases.
    Intern Med. 2025 Aug 7. doi: 10.2169/internalmedicine.5888.
    

    >> Share

    
    

    
    J Autoimmun

28. WANG Y, Wang S, Liu W, Gu H, et al
    Corrigendum to "Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice" [J. Autoimmun. 145 (2024) 103205].
    J Autoimmun. 2025 Aug 2:103470. doi: 10.1016/j.jaut.2025.103470.
    

    >> Share

    
    
29. SENDO S, Vela AJ, Ro M, Thiruppathy D, et al
    Interaction between haploinsufficiency of PTPN2 and patient microbiome promotes autoimmune arthritis in mice.
    J Autoimmun. 2025;156:103452.
    

    >> Share

    
    

    
    J Nephrol

30. EBRAHIMI N, Geetha D, Reyes-Bahamonde J, Zuppan CW, et al
    Effective management of lupus nephritis using a novel combination therapy with low-dose steroids: a case report.
    J Nephrol. 2025 Aug 8. doi: 10.1007/s40620-025-02361.
    

    >> Share

    
    

    
    J Neuroimmunol

31. SAXENA S, Zhirova A, Krishnan R, Healy B, et al
    SARS-CoV-2 spike antibody and T cell response in MS patients on high efficacy therapies post vaccine.
    J Neuroimmunol. 2025;407:578694.
    

    >> Share

    
    
32. YANG C, Jiang X, Cheng Z, Zheng C, et al
    Neuroprotective effects of Analgecine by modifying cholesterol metabolism in EAE mice model of multiple sclerosis.
    J Neuroimmunol. 2025;407:578704.
    

    >> Share

    
    

    
    J Neurol

33. PETERSSON M, Wu J, Berggren F, Schager I, et al
    Impact of disease activity on quality of life and EQ-5D-3L score in myasthenia gravis: results from the Swedish MG registry.
    J Neurol. 2025;272:562.
    

    >> Share

    
    
34. JOHN N, Lim A, Sunthar SR, Zhang L, et al
    Immunotherapies in neuromyelitis optica: Bayesian network meta-analysis.
    J Neurol. 2025;272:563.
    

    >> Share

    
    
35. LEITNER U, Chew SH, Blanch J, Viswanathan M, et al
    Characteristics of MRI lesions in AQP4 antibody-positive NMOSD, MOGAD, and multiple sclerosis: a systematic review and meta-analysis.
    J Neurol. 2025;272:560.
    

    >> Share

    
    
36. MANISCALCO GT, Sparaco M, Di Gregorio M, Cafasso G, et al
    Real-world comparison of lymphopenia profiles in S1P receptor modulators for multiple sclerosis: a multicenter retrospective study.
    J Neurol. 2025;272:559.
    

    >> Share

    
    
37. KERITAM O, Ascoli O, Harsanyi A, Cetin H, et al
    Advanced multiple sclerosis: an exploratory study on a neglected patient population.
    J Neurol. 2025;272:553.
    

    >> Share

    
    
38. CHEN Q, Ma Y, Li Z, Yu C, et al
    Distributions and network changes of brain activity in the acute phase of anti-NMDAR encephalitis: a MEG study.
    J Neurol. 2025;272:551.
    

    >> Share

    
    
39. MENASCU S, Drori T, Kalron A
    Subcortical brain volume changes linked to concern of falling in multiple sclerosis: a structural MRI study.
    J Neurol. 2025;272:552.
    

    >> Share

    
    

    
    J Pediatr Endocrinol Metab

40. TEKE S, Kuloglu Z, Demir AM, Kirsaclioglu CT, et al
    Wolcott-Rallison syndrome: late-onset diabetes, multiple epiphyseal dysplasia, and acute liver failure - a case report.
    J Pediatr Endocrinol Metab. 2025;38:868-872.
    

    >> Share

    
    

    
    J Rheumatol

41. PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al
    School Absence Among Children With Juvenile Idiopathic Arthritis: A National Matched Comparison Study.
    J Rheumatol. 2025;52:801-809.
    

    >> Share

    
    
42. ZIEMBA YC, Elkin EP, Kazemian E, Wilson BM, et al
    COVID-19 vaccine booster uptake and effectiveness among persons with systemic autoimmune and rheumatic diseases.
    J Rheumatol. 2025 Aug 1:jrheum.2025-0535. doi: 10.3899/jrheum.2025-0535.
    

    >> Share

    
    

    
    Neurology

43. AL-ARAJI S, Moccia M, Jha A, Zhang L, et al
    Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2025;105:e213967.
    

    >> Share

    
    
44. MAREFI A, Grasso EA, Canna SW, Behrens EM, et al
    Clinical Reasoning: A 9-Year-Old Girl With CNS Immune Dysregulation.
    Neurology. 2025;105:e213999.
    

    >> Share

    
    

    
    PLoS One

45. MIRMOSAYYEB O, Vaheb S, Afshari-Safavi A, Shaygannejad A, et al
    Long-term effects of air pollution on the incidence and progression of multiple sclerosis: A population cohort study in Isfahan, Iran.
    PLoS One. 2025;20:e0327635.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

46. NEMATULLAH M, Fatma M, Zhou G, Prajapati B, et al
    Immune-responsive gene 1: The mitochondrial key to Th17 cell pathogenicity in CNS autoimmunity.
    Proc Natl Acad Sci U S A. 2025;122:e2427052122.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share